Advanced search
Publication Cover
Acta Oto-Laryngologica Volume 134, 2014 - Issue 8
Submit an article Journal homepage
141
Views
0
CrossRef citations to date
0
Altmetric
ONCOLOGY

A new combined therapy for functional organ preservation and survival in lateral oropharyngeal wall cancer

Tohru FurusakaDepartment of Otolaryngology - Head and Neck Surgery, Nihon University School of Medicine, Tokyo;Laboratory of Veterinary Molecular Pathology and Therapeutics, Division of Animal Life Science, Graduate School, Institute of Symbiotic Science and Technology, Tokyo University of Agriculture and Technology, Tokyo, JapanCorrespondence[email protected]
,
Akira MatsudaLaboratory of Veterinary Molecular Pathology and Therapeutics, Division of Animal Life Science, Graduate School, Institute of Symbiotic Science and Technology, Tokyo University of Agriculture and Technology, Tokyo, Japan
,
Akane TanakaLaboratory of Veterinary Molecular Pathology and Therapeutics, Division of Animal Life Science, Graduate School, Institute of Symbiotic Science and Technology, Tokyo University of Agriculture and Technology, Tokyo, Japan
,
Hiroshi MatsudaLaboratory of Veterinary Molecular Pathology and Therapeutics, Division of Animal Life Science, Graduate School, Institute of Symbiotic Science and Technology, Tokyo University of Agriculture and Technology, Tokyo, Japan
,
Takeshi AsakawaDepartment of Otolaryngology - Head and Neck Surgery, Nihon University School of Medicine, Tokyo
&
Shuntaro ShigiharaDepartment of Otolaryngology - Head and Neck Surgery, Nihon University School of Medicine, Tokyo
Pages 872-880 | Received 27 Dec 2013, Accepted 10 Feb 2014, Published online: 15 Jul 2014

References

  • Furusaka T, Asakawa T, Tanaka A, Matsuda H, Ikeda M. Efficacy of multidrug superselective intra-arterial chemotherapy (docetaxel, cisplatin, and 5-fluorouracil) using the Seldinger technique for tongue cancer. Acta Otolaryngol 2012;132:1108–14.
  • Furusaka T, Matsuda H, Saito T, Katsura Y, Ikeda M. Long-term follow-up and salvage surgery in patients with T2N0M0 squamous cell carcinoma of the glottic larynx who received concurrent chemoradiation therapy with carboplatin (CBDCA) – AUC 1.5 vs AUC 2.0. Acta Otolaryngol 2012;132:1215–23.
  • Furusaka T, Susaki Y, Saito T, Katsura Y, Ikeda M. Long-term follow-up and salvage surgery in patients with T2N0M0 squamous cell carcinoma of the glottic larynx following concurrent chemoradiation therapy with cisplatin and 5-fluorouracil for laryngeal preservation. Acta Otolaryngol 2013;133:91–8.
  • Furusaka T, Matsuda A, Saito T, Katsura Y, Ikeda M. Concurrent chemoradiation therapy with docetaxel (DOC) for laryngeal preservation in T2N0M0 glottic squamous cell carcinomas. Acta Otolaryngol 2013;133:99–112.
  • Furusaka T, Matsuda A, Tanaka A, Matsuda H, Ikeda M. Superselective intra-arterial chemotherapy for laryngeal preservation in carcinoma of the anterior oropharyngeal wall. Acta Otolaryngol 2013;133:194–202.
  • Furusaka T, Sasaki CT, Matsuda A, Susaki Y, Matsuda H, Ikeda M. Multidrug resistance in mucoepidermoid carcinoma of the parotid gland – immunohistochemical investigations of P-glycoprotein expression. Acta Otolaryngol 2013;133:552–7.
  • Furusaka T, Matsuda A, Tanaka A, Matsuda H, Ikeda M. Superselective intra-arterial chemoradiation therapy for functional laryngeal preservation in advanced squamous cell carcinoma of the glottic larynx. Acta Otolaryngol 2013;133:633–40.
  • Matsuura K, Saijo S, Ogawa T, Hanazawa H, Sariishi T, Kiyokawa H. A study of the surgical treatment and post-operative functional assessment for carcinoma of anterior oropharyngeal wall. J Jpn Soc Head Neck Surg 2007;17:27–33.
  • Matsuo M, Rikimaru F, Higaki Y, Tomita K. Clinical analysis of intra-arterial concurrent chemoradiotherapy for oropharyngeal carcinoma of the anterior, posterior, and superior walls. Jpn J Head Neck Cancer 2009;35:25–30; in Japanese.
  • Mori K, Nakashima T, Hirano M, Kojima K, Hayabuchi N, Kiyokawa K, et al. Combined therapy approach for carcinoma of the oropharynx – comparison with previous outcomes. Pract Otol Rhinol Laryngol 1998;91:291–8.
  • Yamamoto N, Kitamura H, Takagita S, Iwahashi Y, Miyazaki M. Oropharyngeal carcinoma. Pract Otol Rhinol Laryngol 2000;93:1051–6.
  • Mikami Y, Tsukuda M, Mochimatsu I, Arai Y, Kawai S, Enomoto H. Clinical outcome of patients with oropharyngeal squamous cell carcinoma. Head Neck Cancer 2001;27:85–90.
  • Ebisumoto K, Okami K, Sakai A, Atsumi T, Maki D, Sugimoto R, et al. Clinical outcome of patients with oropharyngeal squamous cell carcinoma. Jpn J Head Neck Cancer 2011;37:405–10.
  • Chaturvedi AK, Engels EA, Anderson WF, Gillison ML. Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. J Clin Oncol 2008;26:612–19.
  • Parsons JT, Mendenhall WM, Stringer SP, Amdur RJ, Hinerman RW, Villaret DB, et al. Squamous cell carcinoma of the oropharynx. Cancer 2002;94:2967–80.
  • Mowry SE, Ho A, Lotempio MM, Sadeghi A, Blackwell KE, Wang MB. Quality of life in advanced oropharyngeal carcinoma after chemoradiation versus surgery and radiation. Laryngoscope 2006;116:1589–93.
  • Allal AS, Nicoucar K, Mach N, Dulguerov P. Quality of life in patients with oropharynx carcinomas: assessment after accelerated radiotherapy with or without chemotherapy versus radical surgery and postoperative radiotherapy. Head Neck 2003;25:833–40.
  • Pignon JP, le Maitre A, Maillard M, Bourhis J. MACH-NC Collaborative Group. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients. Radiother Oncol 2009;92:4–14.
  • Robbins KT, Strinolo AM, Kerber C, Segren S, Berson A, Howell SB. Rapid superselective high-dose cisplatin infusion for advanced head and neck malignancies. Head Neck 1992;14:364–71.
  • Furusaka T, Tanaka A, Matsuda H, Ikeda M. Consecutive daily low-dose S-1 adjuvant chemotherapy after radical treatment for squamous cell carcinoma in head and neck cancer. Acta Otolaryngol 2011;131:1099–103.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.